Which drugs does patent 8,791,270 protect, and when does it expire?
Patent 8,791,270 protects TREANDA and BENDEKA and is included in two NDAs. There have been zero Paragraph IV challenges on Bendeka and Treanda
Protection for TREANDA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-two patent family members in twenty-one countries.